NCT04877522 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04877522
Title	Asciminib Roll-over Study
Recruitment	Recruiting
Gender	both
Phase	FDA approved
Variant Requirements	No
Sponsors	Novartis Pharmaceuticals
Indications	acute lymphoblastic leukemia chronic myeloid leukemia
Therapies	Asciminib Bosutinib Dasatinib Nilotinib Asciminib + Imatinib Asciminib + Dasatinib Asciminib + Nilotinib
Age Groups:	adult \| child \| senior
Covered Countries	USA \| TUR \| ROU \| POL \| LBN \| ITA \| GBR \| FRA \| ESP \| DNK \| DEU \| CZE \| CAN \| BRA \| BGR \| AUT \| ARG

NCT04877522
Clinical Trial Detail